Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001815776-24-000071
Filing Date
2024-11-06
Accepted
2024-11-06 07:35:55
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lenz-20240930.htm   iXBRL 10-Q 1541321
2 EX-31.1 exhibit311q324.htm EX-31.1 10747
3 EX-31.2 exhibit312q324.htm EX-31.2 10750
4 EX-32.1 exhibit321q324.htm EX-32.1 5363
5 EX-32.2 exhibit322q324.htm EX-32.2 5366
  Complete submission text file 0001815776-24-000071.txt   6483928

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lenz-20240930.xsd EX-101.SCH 38608
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lenz-20240930_cal.xml EX-101.CAL 56158
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lenz-20240930_def.xml EX-101.DEF 215907
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lenz-20240930_lab.xml EX-101.LAB 533022
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lenz-20240930_pre.xml EX-101.PRE 375373
62 EXTRACTED XBRL INSTANCE DOCUMENT lenz-20240930_htm.xml XML 698401
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 241429257
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)